FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912161722> ?p ?o ?g. }

• W2912161722 endingPage "S116" @default.
• W2912161722 startingPage "S115" @default.
• W2912161722 abstract "Introduction Older pts with AML often have significant comorbidities and other geriatric health problems, and the effect of these on the probability of receiving HCT is unknown. We designed a prospective, longitudinal, observational study of adult pts with AML dating from first presentation at one of 13 centers. We examined the effects of different variables on the probability to 1) survive long enough to receive HCT and 2) to receive HCT if such survival occurred. Methods We enrolled 695 pts (Table 1). Data on demographics, AML status, cytogenetic risks per European Leukemia Network (ELN), response, age, comorbidities per the HCT-comorbidity index (CI), function, frailty, geriatric assessment, cognition, Karnofsky performance status (KPS), QOL, social support, and depression were collected at enrollment and at 1, 3, 6, 9, 12, 18, and 24 months thereafter. We used competing risk Cox regression analyses, treating HCT as the event of interest and death without HCT as a competing risk, with staggered entry (left truncation) at time of consent. Associations between variables were assessed both at enrollment and over time. Results The overall rate of HCT at 9 months after enrollment was 43% (Figure 1) and 92% who received HCT did so by 9 months. In multivariate analyses, death without HCT (Table 2) was associated with augmented HCT-CI scores ≥5, age ≥50 years with those aged ≥70 years having the highest association, ELN intermediate or unfavorable risks, receiving low-intensity induction regimens, relapsed/refractory disease at enrollment, dependent status per ADL scores Among survivors (Table 3), low likelihood to receive HCT was associated with age ≥70 years, low ELN risk, low-intensity induction, poor KPS, and relapse after initial complete remission (CR); while pts with high-risk MDS, relapsed/refractory disease at enrollment, and CR after induction were more likely to receive HCT. Among pts aged ≥60 years, and after considering previous factors, impaired cognition and hearing had a lower likelihood to receive HCT. Conclusions Increasing age, comorbidity burden, ELN risk, low-intensity initial AML induction regimen, depression, and functional dependence increase risks of early mortality without HCT. In those who survived long enough to potentially receive HCT, age up to 69 years and/or multiple comorbidities were not found to be barriers to HCT, likely reflecting the widespread use of reduced-intensity conditioning regimens. The adverse impact of impairments in psychological health and function on survival and of impairments of cognition, geriatric health, and performance status on receipt of HCT emphasize the need for interventions that target these health limitations in conjunction with AML treatment to improve outcomes. Finally, the benefit of intensive vs. less-intensive induction therapies should be addressed with a randomized trial." @default.
• W2912161722 created "2019-02-21" @default.
• W2912161722 creator A5000838010 @default.
• W2912161722 creator A5011099910 @default.
• W2912161722 creator A5014838335 @default.
• W2912161722 creator A5015218987 @default.
• W2912161722 creator A5019215418 @default.
• W2912161722 creator A5021141790 @default.
• W2912161722 creator A5021921003 @default.
• W2912161722 creator A5023728016 @default.
• W2912161722 creator A5035330164 @default.
• W2912161722 creator A5038660651 @default.
• W2912161722 creator A5041166424 @default.
• W2912161722 creator A5046097970 @default.
• W2912161722 creator A5047298186 @default.
• W2912161722 creator A5049910941 @default.
• W2912161722 creator A5051018931 @default.
• W2912161722 creator A5052269343 @default.
• W2912161722 creator A5055740968 @default.
• W2912161722 creator A5056405520 @default.
• W2912161722 creator A5057920623 @default.
• W2912161722 creator A5061865992 @default.
• W2912161722 creator A5066644663 @default.
• W2912161722 creator A5070467855 @default.
• W2912161722 creator A5074380791 @default.
• W2912161722 creator A5076933593 @default.
• W2912161722 creator A5077272360 @default.
• W2912161722 creator A5082072227 @default.
• W2912161722 creator A5084791637 @default.
• W2912161722 creator A5084915025 @default.
• W2912161722 date "2019-03-01" @default.
• W2912161722 modified "2023-09-30" @default.
• W2912161722 title "Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study" @default.
• W2912161722 doi "https://doi.org/10.1016/j.bbmt.2018.12.392" @default.
• W2912161722 hasPublicationYear "2019" @default.
• W2912161722 type Work @default.
• W2912161722 sameAs 2912161722 @default.
• W2912161722 citedByCount "0" @default.
• W2912161722 crossrefType "journal-article" @default.
• W2912161722 hasAuthorship W2912161722A5000838010 @default.
• W2912161722 hasAuthorship W2912161722A5011099910 @default.
• W2912161722 hasAuthorship W2912161722A5014838335 @default.
• W2912161722 hasAuthorship W2912161722A5015218987 @default.
• W2912161722 hasAuthorship W2912161722A5019215418 @default.
• W2912161722 hasAuthorship W2912161722A5021141790 @default.
• W2912161722 hasAuthorship W2912161722A5021921003 @default.
• W2912161722 hasAuthorship W2912161722A5023728016 @default.
• W2912161722 hasAuthorship W2912161722A5035330164 @default.
• W2912161722 hasAuthorship W2912161722A5038660651 @default.
• W2912161722 hasAuthorship W2912161722A5041166424 @default.
• W2912161722 hasAuthorship W2912161722A5046097970 @default.
• W2912161722 hasAuthorship W2912161722A5047298186 @default.
• W2912161722 hasAuthorship W2912161722A5049910941 @default.
• W2912161722 hasAuthorship W2912161722A5051018931 @default.
• W2912161722 hasAuthorship W2912161722A5052269343 @default.
• W2912161722 hasAuthorship W2912161722A5055740968 @default.
• W2912161722 hasAuthorship W2912161722A5056405520 @default.
• W2912161722 hasAuthorship W2912161722A5057920623 @default.
• W2912161722 hasAuthorship W2912161722A5061865992 @default.
• W2912161722 hasAuthorship W2912161722A5066644663 @default.
• W2912161722 hasAuthorship W2912161722A5070467855 @default.
• W2912161722 hasAuthorship W2912161722A5074380791 @default.
• W2912161722 hasAuthorship W2912161722A5076933593 @default.
• W2912161722 hasAuthorship W2912161722A5077272360 @default.
• W2912161722 hasAuthorship W2912161722A5082072227 @default.
• W2912161722 hasAuthorship W2912161722A5084791637 @default.
• W2912161722 hasAuthorship W2912161722A5084915025 @default.
• W2912161722 hasBestOaLocation W29121617221 @default.
• W2912161722 hasConcept C126322002 @default.
• W2912161722 hasConcept C188816634 @default.
• W2912161722 hasConcept C207103383 @default.
• W2912161722 hasConcept C23131810 @default.
• W2912161722 hasConcept C2779159551 @default.
• W2912161722 hasConcept C2911091166 @default.
• W2912161722 hasConcept C44249647 @default.
• W2912161722 hasConcept C50382708 @default.
• W2912161722 hasConcept C71924100 @default.
• W2912161722 hasConceptScore W2912161722C126322002 @default.
• W2912161722 hasConceptScore W2912161722C188816634 @default.
• W2912161722 hasConceptScore W2912161722C207103383 @default.
• W2912161722 hasConceptScore W2912161722C23131810 @default.
• W2912161722 hasConceptScore W2912161722C2779159551 @default.
• W2912161722 hasConceptScore W2912161722C2911091166 @default.
• W2912161722 hasConceptScore W2912161722C44249647 @default.
• W2912161722 hasConceptScore W2912161722C50382708 @default.
• W2912161722 hasConceptScore W2912161722C71924100 @default.
• W2912161722 hasIssue "3" @default.
• W2912161722 hasLocation W29121617221 @default.
• W2912161722 hasOpenAccess W2912161722 @default.
• W2912161722 hasPrimaryLocation W29121617221 @default.
• W2912161722 hasRelatedWork W1964112693 @default.
• W2912161722 hasRelatedWork W2027566078 @default.
• W2912161722 hasRelatedWork W2048151760 @default.
• W2912161722 hasRelatedWork W2080970589 @default.
• W2912161722 hasRelatedWork W2791445737 @default.
• W2912161722 hasRelatedWork W2817153975 @default.
• W2912161722 hasRelatedWork W2912161722 @default.
• W2912161722 hasRelatedWork W2921479787 @default.

• next